NOVO NORDISK A S (NVO)
Clinical trial NCT07597018 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-05-28 → 2027-06-01
Clinical trial NCT07597018 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-05-28 → 2027-06-01
Clinical trial NCT07198087 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-12-31 → 2026-04-20
Clinical trial NCT03981640 updates: 1. completion date: 2026-04-01 → 2026-08-01 2. primary completion date: 2026-04-01 → 2026-08-01
Clinical trial NCT04645589 updates: 1. completion date: 2025-06-13 → 2025-08-13 2. primary completion date: 2025-06-13 → 2025-08-13 3. enrollment: 72 → 69 participants
Clinical trial NCT04940052: completion date: 2027-05-17 → 2027-05-25.
Clinical trial NCT04122976 updates: 1. completion date: 2026-12-30 → 2026-10-07 2. primary completion date: 2026-12-30 → 2026-07-07
Clinical trial NCT07470866 updates: 1. status: RECRUITING → TERMINATED 2. primary completion date: 2026-06-02 → 2026-05-12 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05913687 updates: 1. completion date: 2026-03-31 → 2027-03-31 2. primary completion date: 2026-03-31 → 2027-03-31
Clinical trial NCT06366451 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-04-01 → 2026-03-25 3. primary completion date: 2025-02-01 → 2026-03-25 4. enrollment: 15 → 17 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07433322: start date: 2026-05-01 → 2026-06-01.